US EditionUS Appeals Court Upholds West Virginia Restriction on Abortion Pill Sales
WEST VIRGINIA, UNITED STATES, JUL 18 – The 4th Circuit ruled states can restrict mifepristone despite FDA approval, with medication abortions comprising 63% of U.S. abortions in 2023, according to the Guttmacher Institute.
- A federal appeals court upheld a lower court's decision restricting abortion pill sales in West Virginia on July 15, 2025.
- The 4th U.S. Circuit Court of Appeals determined that the FDA's approval of mifepristone did not preempt West Virginia's law on medication abortions, which represents over half of U.S. abortions.
- Judge J. Harvie Wilkinson stated that the federal law from 2007 did not demonstrate an intention to displace states' rights regarding health and safety.
- GenBioPro challenged West Virginia's law, which may create barriers to healthcare for many residents.
53 Articles
53 Articles
Attacks on Abortion Access Are as Old as White Supremacist Patriarchy Itself. Here’s How We Fight Back.
What really underlies attacks on our bodily autonomy isn’t a devotion to “life,” but a desire for dominance. “In the history of abortion, every single time there is a wave of criminalization of abortion, it’s at the same time that the people in power, the forces that be, are concerned about losing power,” says Renee Bracey Sherman. In the second episode of Looking Back, Moving Forward, advocates, lawmakers and experts explore the real roots of a…
West Virginia ban on mifepristone’s use in abortion upheld by federal court
A divided federal appeals court on July 15 upheld a West Virginia law restricting the use of drugs when the intent is to use them for abortion, such as mifepristone, which is sometimes also used for managing early miscarriage.
The state of mind of the pro-life movement went from jubilant to gloomy in the three years after the Supreme Court overturned the national right to abortion in Dobbs, while voters in the red states consolidated protections for abortion and SCOTUS unanimously rejected the doctors' challenge to the relaxed rules of the Food and Drug Administration for abortion pills.Read more]]>
WV can restrict abortion pill access, appeals court rules; Morrisey calls it 'big win'
The Fourth Circuit Court of Appeals ruled Tuesday, July 15, 2025, in a 2-1 vote that West Virginia can restrict access to the abortion pill mifepristone, dismissing a challenge from drug manufacturer GenBioPro.
Coverage Details
Bias Distribution
- 42% of the sources lean Left
To view factuality data please Upgrade to Premium
